A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors

Clinical trial NCT04686682 · RECRUITING

Trial details

NCT number: NCT04686682
Sponsor: Jacobio Pharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

NSCLC SCLC CRPC ESCC Ovarian Carcinoma AML MF Malignant Tumor

Start date: 2021-05-07
Primary completion: 2028-01-01
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.